In the first quarter of 2026, the global market for low-value medical consumables continued its recovery trajectory, reaching a total market size of $31.86 billion—a year-on-year increase of 5.8%. Core product categories—including first aid kits, medical dressings, sharps containers, and *in vitro* diagnostic (IVD) rapid test cards for humans—all demonstrated robust growth. Notably, pet diagnostic reagents and pet healthcare products remained the fastest-growing sub-segments within the market.
From a regional perspective, the Asia-Pacific region led the global market with a size of $10.19 billion, capturing a 31.9% market share and recording a year-on-year growth of 7.9%. The North American market reached $9.24 billion (accounting for 29.0% of the market, with 4.2% year-on-year growth), while the European market reached $7.65 billion (accounting for 24.0%, with 4.7% year-on-year growth). Driven by the European Union's Medical Device Regulation (MDR), demand within the European market for high-quality, compliant medical consumables continued its upward trend.
Emerging markets demonstrated strong performance: the Middle East grew by 9.1%, driven primarily by substantial government procurement of emergency supplies, medical dressings, and IVD products; Latin America grew by 6.8%; and the African region grew by 8.5%, reflecting a significant demand for cost-effective, basic medical consumables.
Growth across specific sub-segments was as follows: first aid supplies grew by 7.2%; medical dressings by 6.5%; sharps containers by 5.1%; and human POCT (Point-of-Care Testing) test cards by 8.3%. Pet diagnostic kits and pet healthcare products surged by 12.7%, leading the entire industry in terms of growth rate. The relaxation of Over-the-Counter (OTC) regulations regarding home-based pet testing in Europe and North America provided a powerful boost to export demand for canine and feline test strips, as well as pet nutrition products.
In summary, the global market is currently undergoing a steady recovery during the first half of 2026. Mature markets are prioritizing regulatory compliance upgrades, while emerging markets have emerged as the primary drivers of incremental demand. Export-oriented enterprises possessing comprehensive product lines, complete international certification credentials, and the capability to offer integrated "human and pet" healthcare solutions are poised to continue reaping the benefits of this market expansion.
